Article info

PDF

Original article
Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial

Authors

  1. Correspondence to Professor Robin C Spiller, Nottingham Digestive Diseases Centre, University of Nottingham, Queens Medical Centre, Nottingham NG7 2UH, UK; robin.spiller{at}nottingham.ac.uk
View Full Text

Citation

Major G, Bradshaw L, Boota N on behalf of RAPID Collaboration Group, et al
Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial

Publication history

  • Received May 12, 2018
  • Revised August 28, 2018
  • Accepted August 29, 2018
  • First published September 25, 2018.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.